Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Ted Raad
|
| gptkbp:developsTreatmentFor |
gptkb:allergic_bronchopulmonary_aspergillosis
chronic obstructive pulmonary disease idiopathic pulmonary fibrosis respiratory diseases |
| gptkbp:focusesOn |
inhaled therapies
|
| gptkbp:foundedYear |
2003
|
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pulmatrix
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:platform |
iSPERSE
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
PULM
|
| gptkbp:website |
https://www.pulmatrix.com/
|
| gptkbp:bfsParent |
gptkb:Terry_McGuire
|
| gptkbp:bfsLayer |
7
|